Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Galectin Therapeutics Inc (GALT)

Healthcare Biotechnology
3.00 $
-8.0% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Galectin Therapeutics Inc (GALT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.7% of the shares are freely tradable; institutional investors hold 21.2%.

Ownership Structure

Institutional ownership
21.2%
Insiders
29.1%
Float
71.7%
Short % of float
18.7%
Shares Outstanding
66Mio.

Largest Shareholders

Institutions

Institutions GALT
Name Stake (%) Shares Change (%) Date
Vanguard Group Inc 3.48 2,288,848 +1.8 12/31/2025
Vanguard Capital Management, LLC 2.99 1,966,542 +0.0 03/31/2026
Marshall Wace Asset Management Ltd 1.85 1,219,912 +102.6 03/31/2026
Advisor Group Holdings, Inc. 1.70 1,122,670 +2.9 03/31/2026
BlackRock Inc 1.21 799,237 +0.3 03/31/2026
Millennium Management LLC 1.21 798,434 +239.0 03/31/2026
Sontag Advisory LLC 1.10 721,788 +19.9 03/31/2026
Geode Capital Management, LLC 0.93 612,786 +2.5 03/31/2026

Funds

Funds GALT
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 2.05 1,351,443 +0.0 04/30/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.91 596,816 +5.9 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
14. Jul 2026 Jamil Khurram Chief Medical Officer Sell 16,250 5.13 83,285
14. Jul 2026 Jamil Khurram Chief Medical Officer Other 16,250 3.04 49,400

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?